The ANUWELL Guide to Perimenopause
What is changing, why it starts earlier than you think, and what a guided path actually looks like.
Key takeaways
- Earlier
Perimenopause typically begins in the early to mid 40s, sometimes the late 30s, and it is driven by erratic hormones, not simply low ones.
- Pattern
The symptoms cluster: sleep, mood, cycles, cognition, temperature, metabolism, and genitourinary changes all trace to one process.
- Diagnosis
No single blood test diagnoses it. The diagnosis is clinical: your age, cycle history, and symptom pattern, read together.
- Individual path
Hormone therapy is a legitimate option evaluated individually, and strength, protein, sleep, and recovery matter on every path.
By the numbers
Perimenopause, in four figures
- Early 40s
- when the transition most commonly begins, sometimes the late 30s. 1
- 4 to 8 yrs
- the typical length of the transition, though it varies widely. 1
- 7.4 yrs
- median duration of hot flashes and night sweats for women who get them. 3
- 2002
- the year one study reshaped hormone therapy care. The correction is still catching up. 9
THE STARTING POINT
You are not imagining it
Maybe sleep changed first. Then the word you knew perfectly well started disappearing mid-sentence. Workouts felt different, your patience got shorter, or your body stopped responding quite the way it used to. You mentioned it to your doctor and were told your labs looked fine.
Or perhaps it showed up another way. A cycle that had been predictable for years suddenly changed. Waking at 3 a.m. with your mind already running. A new undercurrent of anxiety without an obvious reason. Weight shifting toward your midsection even though your habits had not changed.
Any one of these things can have many explanations: stress, age, a difficult season, poor sleep. It is often the pattern that gets your attention, the sense that several things are changing at once.
Perimenopause is the transition leading up to menopause, when ovarian hormone production becomes more variable and less predictable. It commonly begins in the 40s, though it can start earlier, and the transition can last for several years. Symptoms and timing look different for every woman.
It is not a disease, and there is no single “right” way to experience it. But understanding what is changing can make the transition easier to recognize, talk about, and manage.
THE MECHANISM
What perimenopause actually is
The words get used interchangeably and they should not be. Menopause is a single day: the day that marks twelve months since your final period. Everything after it is postmenopause. Everything before it, the years when hormones shift and symptoms surface, is perimenopause. 2
Perimenopause is not low estrogen. It is erratic estrogen. For most of the transition, estrogen does not slide gently downhill. It swings, sometimes higher than it ran in your 30s, sometimes sharply lower, occasionally both in the same month. 1 Progesterone behaves differently. It depends on ovulation, and as ovulation becomes less regular, progesterone declines more steadily and often earlier. So the two hormones your body spent three decades balancing are now moving on different schedules, and many of the strangest symptoms of this phase trace back to that volatility rather than to any simple deficiency.
The mechanism, in plain language: your brain and your ovaries run a continuous conversation. The hypothalamus signals the pituitary, the pituitary instructs the ovaries, and the ovaries answer with estrogen and progesterone, which report back and quiet the signal. You were born with a finite reserve of ovarian follicles, and as that reserve runs low, the ovary's replies become less consistent. The brain, hearing a weaker response, raises its voice. Some months the ovary over-answers; some months it barely answers at all. The loop is not broken. It is noisy, and a noisy signal in a system this central shows up everywhere: sleep, mood, temperature, cognition, metabolism. 12
Most women are years into the transition before anyone names it, partly because the early changes are subtle and partly because almost nobody tells women in their 30s that this is coming.

Download the guide
A guide to keep close
Download a printable version of this guide.
Download the guidePDF · 11 pages · printable
THE SIGNAL SET
Seven clusters, one process
No two women experience perimenopause identically, which is one reason it hides in plain sight. But the symptoms are not random. They cluster, and each cluster traces back to the same signal instability. Notice which ones are yours: one alone means little, while three or four together, in this decade of life, tell a coherent story.
- 01
Sleep
The classic version is the 3am waking: falling asleep is fine, staying asleep is not. Progesterone is part of why. One of its byproducts acts on the same calming receptors in the brain that sleep medications target, so as progesterone declines, a quiet natural sedative begins to withdraw. 5 Night sweats, for some women, break sleep further.
- 02
Mood & Anxiety
Irritability that feels unfamiliar. Feeling more emotionally reactive. Anxiety that appears or intensifies without an obvious change in your circumstances. For some women, mood changes become one of the most noticeable symptoms of the transition. Estrogen interacts with serotonin and the brain's stress-response systems, and research suggests that hormone fluctuation, rather than simply having a low hormone level, may contribute to changes in mood during perimenopause. 6 If the way you feel has noticeably changed, that information belongs in the clinical conversation.
- 03
Cycles
For women who menstruate naturally, cycle changes are often one of the earliest visible signs of perimenopause. Cycles may shorten at first and later become more irregular: closer together, further apart, heavier, lighter, or occasionally skipped. 2 But cycles are not a useful signal for everyone. Hormonal birth control can regulate, alter, or suppress bleeding, making the usual menstrual signs of perimenopause less obvious. 19 In those cases, a clinician may rely more heavily on age, symptoms, medical history, and the type of contraception being used rather than cycle changes alone. Certain hormonal contraceptives can also affect the interpretation of hormone testing, which is another reason perimenopause should not be reduced to a single lab result. 19 Significant or unexplained changes in bleeding still deserve their own clinical evaluation rather than being automatically attributed to perimenopause. 8
- 04
Cognition
Word-finding pauses. Walking into a room and forgetting why. A fog over focus that can feel unfamiliar or unsettling. Cognitive complaints are common during the menopause transition, and studies following women through this period have found changes in some areas of cognitive performance that are often temporary. 7 Estrogen receptors are distributed throughout the brain, including regions involved in memory and attention, which may help explain why changing hormone patterns can affect how clearly you feel you are thinking. These symptoms do not, on their own, point to a more serious cognitive disorder, but persistent or worsening changes are always worth discussing with a clinician.
- 05
Temperature
Hot flashes and night sweats are the symptoms everyone knows. The brain's temperature control center sits in the hypothalamus, dense with estrogen receptors, and as the signal fluctuates, the range of temperatures your body tolerates narrows. Small shifts you once absorbed without noticing now trigger a full cooling response: flushing, sweating, a racing heart. 4 Up to eight in ten women experience these at some point. Some barely notice them; some live with them for years. 34
- 06
Body Composition & Metabolism
Weight shifting toward the midsection even though your habits have not changed. Strength becoming harder to maintain. Recovery taking longer than it used to. These changes are easy to write off as “just getting older,” but the menopause transition itself can contribute to changes in fat distribution, insulin sensitivity, and muscle. 12 It gets a full read below.
- 07
Libido & Genitourinary
Desire that has gone quiet. Comfort during sex that has changed. More frequent urinary symptoms or infections. Estrogen maintains the tissue of the genital and urinary tract, and declining levels change that tissue in ways that are physical, common, and treatable. 11 Nothing in this cluster is a verdict on you or your relationship. It is biology, it responds to care, and you can be the one to bring it up first.
THE HISTORY
Why so many women were dismissed
If you recognize yourself across several of these clusters, they may be more connected than they first appear. Rather than treating each symptom in isolation, a good clinical conversation looks at the pattern as a whole.
If you have brought this pattern to a doctor and left with a shrug, a depression screening, or the phrase “your labs are normal,” you are in large company. Part of the explanation is structural. Menopause medicine occupies a small corner of most medical training, and a seven-minute appointment is not built for a symptom story with seven chapters. A cluster that spans sleep, mood, cognition, weight, and cycles gets routed to five different specialties, and no one sees the whole picture.
The larger part has a date on it: 2002. That year the Women's Health Initiative, a major study of hormone therapy in postmenopausal women, stopped one of its arms early after reporting increased risks including breast cancer and cardiovascular events. 9 The coverage was everywhere before most physicians had read the paper, hormone therapy prescriptions collapsed almost overnight, and a generation of physicians learned to steer clear.
The two decades since have clarified what the original WHI findings did, and did not, mean. The women in the study averaged 63 years old, and many were more than a decade past menopause when they began hormone therapy. Subsequent analyses of the WHI data, along with newer research, showed that age and timing matter: the balance of benefits and risks is not the same for a woman starting therapy near menopause as it is for someone beginning many years later. 10
That evidence changed clinical guidance. Today, major menopause societies consider hormone therapy an effective option for many symptomatic women, with the decision based on factors including age, time since menopause, symptoms, health history, and individual risk. 11 The shift was not that the original study was simply “wrong.” It was that its findings had been applied too broadly.
None of this means hormone therapy is right for you. The point is narrower and more important: the confusion you have met is inherited from history, not evidence that your symptoms are unserious. Care in 2026 should be built on the evidence of 2026.
If you have received conflicting advice about hormones, you are not behind. You are caught in the wake of one study, one press conference, and twenty years of course correction that never got equal airtime.
THE METABOLIC CONNECTION
Weight, muscle, and the loop that feeds itself
Estrogen is not just a reproductive hormone. It is a metabolic one. It supports insulin sensitivity, the efficiency with which your cells manage blood sugar. It influences where your body stores fat, favoring hips and thighs through the reproductive years. And it supports the maintenance of muscle. As the signal becomes erratic and trends downward, all three jobs get done differently: insulin sensitivity tends to decline, fat storage shifts toward the abdomen, including the deeper visceral fat around the organs, and the slow age-related loss of muscle picks up speed. 12 That last one matters doubly, because muscle is the largest disposal site for blood sugar in your body. 13 Less muscle means less metabolic headroom, which encourages more central fat storage, which further works against insulin sensitivity. The loop feeds itself.
Read that paragraph again and notice what is absent from it: willpower. The habits that worked at 35 stop working at 47 not because you got lazy but because your physiology changed. “Eat less, move more,” delivered as a complete answer, ignores the conditions that changed underneath.
It also points at the real answer: hormones and metabolism treated as a single conversation. Strength training and protein stop being fitness preferences and become metabolic strategy, because preserving muscle defends your insulin sensitivity, your body composition, and your future strength all at once. A woman who walks in through the weight door deserves to have her hormones examined. A woman who walks in through the hormone door deserves to have her metabolic health examined. At ANUWELL these are not treated separately, because in your body they are not separate systems.
TESTING
What labs can and cannot tell you
Here is a sentence you will rarely read on a website that sells lab work: there is no blood test that diagnoses perimenopause.
The reason is the volatility you now understand. Hormone levels swing widely during the transition, sometimes within a single week, and a blood draw catches one moment of a moving level. Catch a high-estrogen day and your results look like a 35-year-old's; catch a low one and they look postmenopausal. FSH, the pituitary hormone often used as a menopause marker, fluctuates the same way during the transition years. 12 This is exactly why so many women with textbook symptom patterns are told their labs are normal. The labs are not wrong. They are answering a different question than the one being asked.
Perimenopause is identified clinically: your age, your cycle history, and your symptom pattern, read together. 1 A physician who starts there is starting in the right place. Testing has three honest jobs:
Ruling out other explanations. Symptoms that overlap with perimenopause can also come from thyroid dysfunction, iron deficiency, anemia, blood sugar changes, or other conditions. Targeted baseline testing may include thyroid markers, a complete blood count, iron and ferritin, glucose or A1C, and other tests based on your symptoms and history. The goal is to make sure the symptoms being attributed to perimenopause are not being driven by something else.
Establishing a broader baseline. Hormone health does not exist in isolation. Lipids, blood sugar regulation, liver function, and other metabolic markers help show what is happening across the systems that often change during this stage of life. This broader view can be more useful than looking at reproductive hormones alone.
Adding hormone context when it is useful. A few top-line values such as estradiol or FSH provide only a snapshot, and during perimenopause those numbers can change significantly from one day or cycle to the next. 12 Depending on your symptoms, cycle pattern, medications, and health history, a clinician may look at a wider set of hormone-related markers and interpret them together rather than relying on one number in isolation. The purpose is not to “prove” perimenopause with a lab result, but to add context to the clinical picture and create a more informed starting point.
Testing is most useful when it answers a specific question: ruling something out, establishing a baseline, or adding context that can change the plan. The value is not in collecting more numbers. It is in knowing which numbers matter and how to interpret them together.
HORMONE THERAPY
How hormone therapy is evaluated
Sooner or later, most women in this transition encounter the question: what about hormone therapy? The internet tends to answer with certainty in both directions. The evidence is more nuanced.
Hormone therapy most commonly uses estrogen, with a progestogen added for women with a uterus who use systemic estrogen. It can be delivered through the skin, taken orally, or used locally for vaginal and urinary symptoms. Route, dose, and formulation matter, which is why treatment should be individualized. 11
WHAT THE EVIDENCE SHOWS: Hormone therapy is the most effective treatment for hot flashes and night sweats, effectively treats genitourinary symptoms, and systemic therapy helps protect against menopause-related bone loss. For many healthy women with bothersome symptoms who begin therapy near menopause, major menopause societies consider the overall benefit-risk balance favorable when treatment is individually evaluated. 11
There are potential risks, including blood clots, stroke, gallbladder disease, and changes in breast cancer risk, depending on the type of therapy, route, timing, duration, and individual health history. 11 But not using hormone therapy is not the same as choosing “no risk.” Persistent symptoms can affect sleep and quality of life, genitourinary symptoms may continue or worsen, and menopause-related bone loss still needs to be addressed.
WHAT THE EVIDENCE IS LESS CERTAIN ABOUT: Sleep and mood may improve for some women, particularly when those symptoms are tied to hot flashes or night sweats. Research continues into broader effects on cognition, cardiovascular health, metabolism, and other systems. 11
WHAT HORMONE THERAPY DOES NOT REPLACE: Strength training, adequate protein, regular movement, sleep, nutrition, and recovery still matter whether or not hormone therapy is part of the plan.
That is why evaluation matters. Age, symptoms, time since menopause, personal and family history, and conditions such as breast cancer, blood clots, stroke, cardiovascular disease, liver disease, or unexplained bleeding can all change what is appropriate. 11
Non-hormonal options are also valid. Prescription treatments, cognitive behavioral therapy for insomnia, and lifestyle strategies can all play a role. 17 Choosing not to use hormone therapy, or not being a candidate for it, does not mean there are no options.
At ANUWELL, completing an assessment does not guarantee a prescription. Hormone therapy is prescribed only when clinically appropriate following review by a licensed physician.
The right question is not whether hormone therapy is good or bad. It is whether it is appropriate for you, at this point in your transition, with your history on the table. That is a question a physician answers with you.
THE LEVERS IN YOUR HANDS
Four moves that work on every path
Whatever you and a physician decide about therapy, these four belong to you outright. None of them are consolation prizes. They determine how well any path works, hormonal or not, and this decade raises the return on every one of them.
- 01
Strength
Muscle is your metabolic reserve, your blood sugar disposal system, your bone protection, and the tissue this transition erodes fastest if unopposed. 1213 Two to three genuinely challenging sessions a week, where the last repetitions are hard, changes the trajectory. 15 If you have lifted for years, take it more seriously now, not less. If you have never lifted, this is the highest-return habit you can begin, and beginning is allowed to look modest.
- 02
Protein
Training is the demand; protein is the supply. The body becomes less efficient at turning dietary protein into muscle with age, so the requirement rises exactly when appetite and habit often drift the other way. 14 Build each meal around a substantial protein anchor, and front-load the day rather than saving it all for dinner.
- 03
Sleep
Short sleep worsens insulin sensitivity, appetite regulation, mood, and next-day stress tolerance, and this transition attacks sleep exactly when you need it most. 16 You cannot fully control the 3am waking, but you can control the conditions around it: a cool, dark room, a consistent wake time anchored by morning light, an earlier caffeine cutoff, and alcohol examined honestly, because it fragments sleep and its cost rises in this decade.
- 04
Recovery
Estrogen and progesterone both help buffer the stress response, so the same load feels heavier now. No one is asking you to breathe your way out of physiology. But recovery is a real biological process, not a personality trait, and building it deliberately into a full calendar, training you enjoy, daylight, unscheduled time, is load management for a system running with less spare capacity.
START HERE
Your next two weeks
Week 1
- Write down the last six months of cycle changes as best you remember, and start tracking from today.
- Note your three loudest symptoms and when they show up. The pattern is the diagnosis, so the record is the preparation.
- Add a protein anchor to breakfast.
Week 2
- Complete two to three resistance-training sessions. You don't need a gym or heavy weights. Bodyweight exercises and resistance bands can provide an effective workout.
- Set a consistent wake time and get morning light.
- If your pattern matches three or more clusters, book a clinical conversation and bring the record with you.
Two weeks will not settle your hormones. It will give you the record and the momentum that make the next conversation a real one.
THE PATH
What guided care looks like
A guided path at ANUWELL starts with an intake built around your actual pattern: your cycle history, symptoms, health history, medications, and goals. A board-certified physician reviews the full picture. When labs would add useful information, such as ruling out other causes or establishing a metabolic baseline, they are ordered with a clear purpose.
From there, you receive a plan based on your individual case. It may include hormone support, metabolic support, both, or a different starting point entirely. The reasoning, benefits, risks, and alternatives should be clear before you decide whether you want to proceed. An assessment does not commit you to a particular treatment.
And because this transition changes over time, the plan can change with it. Follow-up helps your physician understand how you are responding, review relevant markers, and adjust treatment when needed.
What you will not find: templates, one-size dosing, or pressure toward a particular treatment. The goal is clinical judgment applied to your situation, not fitting you into a preset protocol.
If this pattern sounds familiar, the next step is simply to share the full picture. The assessment gives your physician a structured view of what has been changing and what matters most to you. Instead of treating each symptom as a separate problem, guided care starts by looking at how the pieces fit together.
FAQ
Common questions
Most commonly in the early to mid 40s, though it can begin in the late 30s. 1 Because the earliest changes are subtle, many women are several years into the transition before recognizing it. Age plus a changed cycle pattern plus the symptom clusters above is the picture that matters, not any single birthday.
Menopause is a single point in time: the day that marks twelve months since your final period. Perimenopause is the transition leading up to it, when hormone production becomes erratic and most of the symptoms people associate with “menopause” actually occur. Postmenopause is everything after. 2
Not necessarily. Because hormone levels can fluctuate widely during perimenopause, a single blood draw cannot reliably confirm or rule it out. Perimenopause is usually identified from your age, cycle history, symptoms, and overall clinical picture. 1
Labs still play an important role in treatment. Before starting hormone therapy, baseline testing may be required to rule out other causes of your symptoms, assess relevant health and safety markers, and give your physician a clearer starting point for treatment and follow-up. The labs help guide care; they are not a test you have to “pass” to prove you are in perimenopause.
Yes. Ovulation becomes irregular but does not stop until menopause, so pregnancy remains possible throughout the transition. 18 Contraception decisions during perimenopause deserve their own conversation with a physician.
The transition changes how and where the body stores fat, shifting storage toward the abdomen, and it reduces insulin sensitivity and accelerates muscle loss. 12 Together these change how your metabolism works, which is why previous habits often stop producing previous results. It is physiology rather than willpower, and it responds best to a plan built on strength, protein, sleep, and where appropriate, clinical care.
For many symptomatic women who begin therapy near the transition, current evidence and the major menopause societies support it as an effective option whose benefits generally outweigh risks when it is individually evaluated. 11 Personal and family history genuinely change that calculus, which is why appropriate care always starts with a physician reviewing your case. Hormone therapy is prescribed only where clinically appropriate following review by a licensed physician.

The download
Take this guide with you
A printable version of everything above, to keep or share with your clinician.
Download the guidePDF · 11 pages · printable
TERMS INTRODUCED
Terms introduced
| Term | Meaning |
|---|---|
| Perimenopause | The transition years before menopause, when ovarian hormone production becomes erratic; typically four to eight years. |
| Menopause | The single day marking twelve months since the final period. |
| Surgical menopause | Menopause begins immediately when both ovaries are surgically removed; symptoms are often more abrupt, and dedicated clinical guidance matters from the start. |
| Estradiol | The primary form of estrogen during the reproductive years. |
| Progesterone | The hormone produced after ovulation; declines earlier and more steadily than estrogen during the transition. |
| FSH | Follicle-stimulating hormone, the pituitary signal that instructs the ovaries; rises unevenly across the transition, which limits its value as a single-draw test. |
| Vasomotor symptoms | The clinical term for hot flashes and night sweats. |
| Insulin sensitivity | How efficiently your cells respond to insulin; supported by estrogen and by muscle mass. |
| Visceral fat | Deeper abdominal fat surrounding the organs; more metabolically active than fat under the skin. |
| Body composition | The ratio of muscle to fat; a more meaningful measure in this transition than scale weight. |
Educational disclaimer and important safety information
The content in this guide, and throughout the ANUWELL resource library, is provided for general educational and informational purposes only. It is not medical advice, diagnosis, or treatment, and it is not a substitute for the advice of a physician or other licensed healthcare provider. Reading this content does not create a provider-patient relationship with ANUWELL or with any physician. This content summarizes published research and public health sources believed to be reliable as of the date last updated. Medical knowledge changes, individual circumstances differ, and ANUWELL makes no representation or warranty as to the accuracy, completeness, or applicability of this information to your situation. General information can never account for your personal health history. Always consult a licensed healthcare provider before starting, stopping, or changing any medication, supplement, diet, or exercise program, and before acting on anything you read here. Never disregard professional medical advice, or delay seeking it, because of something you have read in this or any ANUWELL content. If you think you may have a medical emergency, call 911 or your local emergency number immediately. Any medical care available through ANUWELL is provided separately by independent licensed physicians and pharmacies, who make all treatment and eligibility decisions based on an individual clinical consultation. Nothing in this guide is a promise or guarantee that any medication or treatment is appropriate for you or will produce any particular result. Any reliance you place on the information in this guide is at your own risk, and to the fullest extent permitted by law, ANUWELL disclaims liability for any loss or injury arising from the use of this content.
Hormone therapy and the other treatments discussed here are prescription medical care and are not appropriate for everyone. Personal and family medical history, including breast cancer, blood clots, stroke, and cardiovascular or liver disease, meaningfully changes whether hormone therapy is appropriate, which is why it is prescribed only where clinically appropriate following review by a licensed physician; completing an assessment does not guarantee a prescription. Report any unusual, heavy, or postmenopausal bleeding to a healthcare provider promptly, as bleeding changes always warrant their own evaluation. If you use hormone therapy, seek immediate medical care for possible signs of a blood clot or stroke, such as chest pain, shortness of breath, leg pain or swelling, sudden severe headache, or sudden changes in vision or speech.
References
- Santoro N. Perimenopause: from research to practice. Journal of Women's Health. 2016;25(4):332-339.
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Journal of Clinical Endocrinology & Metabolism. 2012;97(4):1159-1168.
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. 2015;175(4):531-539.
- Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. Journal of Steroid Biochemistry and Molecular Biology. 2014;142:115-120.
- Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Progress in Brain Research. 2010;186:113-137.
- Gordon JL, Girdler SS, Meltzer-Brody SE, et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. American Journal of Psychiatry. 2015;172(3):227-236.
- Greendale GA, Huang MH, Wight RG, et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. 2009;72(21):1850-1857.
- American College of Obstetricians and Gynecologists. Perimenopausal bleeding and bleeding after menopause.
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368.
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
- Lovejoy JC, Champagne CM, de Jonge L, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. 2008;32(6):949-958.
- DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S157-S163.
- Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association. 2013;14(8):542-559.
- Westcott WL. Resistance training is medicine: effects of strength training on health. Current Sports Medicine Reports. 2012;11(4):209-216.
- Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. The Lancet. 1999;354(9188):1435-1439.
- McCurry SM, Guthrie KA, Morin CM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: the MsFLASH randomized clinical trial. JAMA Internal Medicine. 2016;176(7):913-920.
- Baldwin MK, Jensen JT. Contraception during the perimenopause. Maturitas. 2013;76(3):235-242.




